The operational questions that should dominate a biopharma due diligence
In biopharma transactions, operational due diligence is often the difference between a successful investment and an expensive surprise. Financial performance, market opportunity, and pipeline potential remain critical evaluation areas, but operational realities ultimately determine whether an organization can consistently manufacture, scale, comply, and deliver commercial value. In highly regulated environments, operational weaknesses rarely remain isolated. […]